🔬 Findings from preclinical influenza models led by Dr François Trottein suggest that senolytic drugs could contribute to reducing pulmonary inflammation and certain long‑term tissue damage following severe viral pneumonia, without significantly altering viral load ➡️ pasteur-lille.fr/actualites/u...
